These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33424615)

  • 1. The Protective Role of Immunomodulators on Tissue-Type Plasminogen Activator-Induced Hemorrhagic Transformation in Experimental Stroke: A Systematic Review and Meta-Analysis.
    Ye Y; Zhu YT; Tong HX; Han JY
    Front Pharmacol; 2020; 11():615166. PubMed ID: 33424615
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of Chinese herbal medicine for tPA thrombolysis in experimental stroke: A systematic review and meta-analysis.
    Ye Y; Zhu YT; Xin XY; Zhang JC; Zhang HL; Li D
    Phytomedicine; 2022 Jun; 100():154072. PubMed ID: 35349833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic Agents for tPA-Induced Cerebral Hemorrhage: A Systematic Review and Meta-Analysis of Preclinical Studies.
    Ye Y; Zhang FT; Wang XY; Tong HX; Zhu YT
    J Am Heart Assoc; 2020 Dec; 9(24):e017876. PubMed ID: 33283576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis.
    Dong MX; Hu QC; Shen P; Pan JX; Wei YD; Liu YY; Ren YF; Liang ZH; Wang HY; Zhao LB; Xie P
    PLoS One; 2016; 11(7):e0158848. PubMed ID: 27387385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis.
    Sena ES; Briscoe CL; Howells DW; Donnan GA; Sandercock PA; Macleod MR
    J Cereb Blood Flow Metab; 2010 Dec; 30(12):1905-13. PubMed ID: 20648038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
    Kim JS
    J Stroke; 2019 May; 21(2):160-174. PubMed ID: 31161761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
    Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
    Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R; Xiao AY; Liu S; Wang M; Li G
    Stroke; 2018 Jul; 49(7):1708-1718. PubMed ID: 29844028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorrhagic Transformation in Acute Ischemic Stroke: A Quantitative Systematic Review.
    Honig A; Percy J; Sepehry AA; Gomez AG; Field TS; Benavente OR
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone ameliorates tissue plasminogen activator-induced brain hemorrhage after stroke.
    Li Y; Zhu ZY; Lu BW; Huang TT; Zhang YM; Zhou NY; Xuan W; Chen ZA; Wen DX; Yu WF; Li PY
    CNS Neurosci Ther; 2019 Dec; 25(12):1343-1352. PubMed ID: 31756041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
    García-Yébenes I; García-Culebras A; Peña-Martínez C; Fernández-López D; Díaz-Guzmán J; Negredo P; Avendaño C; Castellanos M; Gasull T; Dávalos A; Moro MA; Lizasoain I
    Stroke; 2018 Sep; 49(9):2163-2172. PubMed ID: 30018160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of extracellular vesicles in preclinical stroke models: a systematic review and meta-analysis.
    Thomas JM; Cunningham CJ; Lawrence CB; Pinteaux E; Allan SM
    BMJ Open Sci; 2020; 4(1):e100047. PubMed ID: 35047689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes Worsens Functional Outcomes in Young Female Rats: Comparison of Stroke Models, Tissue Plasminogen Activator Effects, and Sexes.
    Li W; Ward R; Valenzuela JP; Dong G; Fagan SC; Ergul A
    Transl Stroke Res; 2017 Mar; ():. PubMed ID: 28247188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.
    Dela Peña IC; Yang S; Shen G; Fang Liang H; Solak S; Borlongan CV
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
    Albers GW; Bates VE; Clark WM; Bell R; Verro P; Hamilton SA
    JAMA; 2000 Mar; 283(9):1145-50. PubMed ID: 10703776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential of Biomaterial-Based Approaches as Therapies for Ischemic Stroke: A Systematic Review and Meta-Analysis of Pre-clinical Studies.
    Bolan F; Louca I; Heal C; Cunningham CJ
    Front Neurol; 2019; 10():924. PubMed ID: 31507524
    [No Abstract]   [Full Text] [Related]  

  • 20. Engineered extracellular vesicles for ischemic stroke: a systematic review and meta-analysis of preclinical studies.
    Li P; Yin R; Chen Y; Chang J; Yang L; Liu X; Xu H; Zhang X; Wang S; Han Q; Wei J
    J Nanobiotechnology; 2023 Oct; 21(1):396. PubMed ID: 37904204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.